A detailed history of Fmr LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Fmr LLC holds 303 shares of LUCD stock, worth $327. This represents 0.0% of its overall portfolio holdings.

Number of Shares
303
Previous 1,159 73.86%
Holding current value
$327
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$0.97 - $1.48 $830 - $1,266
-856 Reduced 73.86%
303 $0
Q2 2025

Aug 14, 2025

BUY
$1.09 - $1.65 $658 - $996
604 Added 108.83%
1,159 $1,000
Q1 2025

May 12, 2025

BUY
$0.79 - $1.59 $438 - $882
555 New
555 $0
Q2 2022

Aug 12, 2022

BUY
$1.73 - $3.44 $314 - $626
182 New
182 $0

Others Institutions Holding LUCD

About Lucid Diagnostics Inc.


  • Ticker LUCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,568,500
  • Market Cap $41.7M
  • Description
  • Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...
More about LUCD
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.